Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 209

1.

Prevalence of Potential and Clinically Relevant Statin-Drug Interactions in Frail and Robust Older Inpatients.

Thai M, Hilmer S, Pearson SA, Reeve E, Gnjidic D.

Drugs Aging. 2015 Oct;32(10):849-56. doi: 10.1007/s40266-015-0302-9.

PMID:
26442861
2.

Epidemiology and Clinical Correlates of AKI in Chinese Hospitalized Adults.

Xu X, Nie S, Liu Z, Chen C, Xu G, Zha Y, Qian J, Liu B, Han S, Xu A, Xu X, Hou FF.

Clin J Am Soc Nephrol. 2015 Sep 4;10(9):1510-8. doi: 10.2215/CJN.02140215. Epub 2015 Jul 31.

PMID:
26231194
3.

Potentially inappropriate prescribing detected by STOPP-START criteria: are they really inappropriate?

Lozano-Montoya I, Vélez-Diaz-Pallarés M, Delgado-Silveira E, Montero-Errasquin B, Cruz Jentoft AJ.

Age Ageing. 2015 Sep;44(5):861-6. doi: 10.1093/ageing/afv079. Epub 2015 Jul 13.

PMID:
26175348
4.

Is researching adverse events in hospital deaths a good way to describe patient safety in hospitals: a retrospective patient record review study.

Baines RJ, Langelaan M, de Bruijne MC, Wagner C.

BMJ Open. 2015 Jul 9;5(7):e007380. doi: 10.1136/bmjopen-2014-007380.

5.

Liver enzyme abnormalities in taking traditional herbal medicine in Korea: A retrospective large sample cohort study of musculoskeletal disorder patients.

Lee J, Shin JS, Kim MR, Byun JH, Lee SY, Shin YS, Kim H, Byung Park K, Shin BC, Lee MS, Ha IH.

J Ethnopharmacol. 2015 Jul 1;169:407-12. doi: 10.1016/j.jep.2015.04.048. Epub 2015 May 6.

PMID:
25956676
6.

Identification and evaluation of potentially inappropriate medications (PIMs) in hospitalized geriatric patients using Beers criteria.

Danisha P, Dilip C, Mohan PL, Shinu C, Parambil JC, Sajid M.

J Basic Clin Physiol Pharmacol. 2015 Jul;26(4):403-10. doi: 10.1515/jbcpp-2014-0054.

PMID:
25951131
7.

Is off-label use a risk factor for adverse drug reactions in pediatric patients? A prospective study in an Indian tertiary care hospital.

Saiyed MM, Lalwani T, Rana D.

Int J Risk Saf Med. 2015;27(1):45-53. doi: 10.3233/JRS-150642.

PMID:
25766066
8.

Gestational thyrotoxicosis, antithyroid drug use and neonatal outcomes within an integrated healthcare delivery system.

Lo JC, Rivkees SA, Chandra M, Gonzalez JR, Korelitz JJ, Kuzniewicz MW.

Thyroid. 2015 Jun;25(6):698-705. doi: 10.1089/thy.2014.0434. Epub 2015 Apr 14.

9.

Population-representative incidence of drug-induced acute liver failure based on an analysis of an integrated health care system.

Goldberg DS, Forde KA, Carbonari DM, Lewis JD, Leidl KB, Reddy KR, Haynes K, Roy J, Sha D, Marks AR, Schneider JL, Strom BL, Corley DA, Lo Re V 3rd.

Gastroenterology. 2015 Jun;148(7):1353-61.e3. doi: 10.1053/j.gastro.2015.02.050. Epub 2015 Feb 28.

10.

Risk prediction for adverse events during initiation of sotalol and dofetilide for the treatment of atrial fibrillation.

Agusala K, Oesterle A, Kulkarni C, Caprio T, Subacius H, Passman R.

Pacing Clin Electrophysiol. 2015 Apr;38(4):490-8. doi: 10.1111/pace.12586. Epub 2015 Jan 28.

PMID:
25626340
11.

Cutaneous adverse drug reactions in Indian population: A systematic review.

Patel TK, Thakkar SH, Sharma D.

Indian Dermatol Online J. 2014 Dec;5(Suppl 2):S76-86. doi: 10.4103/2229-5178.146165.

12.

Cardiovascular adverse reactions during antidepressant treatment: a drug surveillance report of German-speaking countries between 1993 and 2010.

Spindelegger CJ, Papageorgiou K, Grohmann R, Engel R, Greil W, Konstantinidis A, Agelink MW, Bleich S, Ruether E, Toto S, Kasper S.

Int J Neuropsychopharmacol. 2014 Oct 31;18(4). pii: pyu080. doi: 10.1093/ijnp/pyu080.

13.

Potential drug-drug interactions in infant, child, and adolescent patients in children's hospitals.

Feinstein J, Dai D, Zhong W, Freedman J, Feudtner C.

Pediatrics. 2015 Jan;135(1):e99-108. doi: 10.1542/peds.2014-2015. Epub 2014 Dec 15.

14.

Adverse drug events identified by triggers at a teaching hospital in Brazil.

Giordani F, Rozenfeld S, Martins M.

BMC Pharmacol Toxicol. 2014 Dec 13;15:71. doi: 10.1186/2050-6511-15-71.

15.

Patient-specific risk factors of adverse drug events in adult inpatients - evidence detected using the Global Trigger Tool method.

Härkänen M, Kervinen M, Ahonen J, Voutilainen A, Turunen H, Vehviläinen-Julkunen K.

J Clin Nurs. 2015 Feb;24(3-4):582-91. doi: 10.1111/jocn.12714. Epub 2014 Nov 13.

PMID:
25393838
16.

Multiple drug intolerance syndrome: a large-scale retrospective study.

Omer HM, Hodson J, Thomas SK, Coleman JJ.

Drug Saf. 2014 Dec;37(12):1037-45. doi: 10.1007/s40264-014-0236-x.

17.

Inappropriate drug use among older persons: is it time for action?

Schoenenberger AW, Stuck AE.

Age Ageing. 2014 Nov;43(6):737-9. doi: 10.1093/ageing/afu140. Epub 2014 Oct 9. No abstract available.

18.

Drug interaction alert override rates in the Meaningful Use era: no evidence of progress.

Bryant AD, Fletcher GS, Payne TH.

Appl Clin Inform. 2014 Sep 3;5(3):802-13. doi: 10.4338/ACI-2013-12-RA-0103. eCollection 2014.

19.

Adverse drug events among adult inpatients: a meta-analysis of observational studies.

Martins AC, Giordani F, Rozenfeld S.

J Clin Pharm Ther. 2014 Dec;39(6):609-20. doi: 10.1111/jcpt.12204. Epub 2014 Sep 15. Review.

PMID:
25219403
20.

Incidence and impact of adverse effects of medical care on complications in patients who underwent excision of cervical lymph nodes.

Allareddy V, Elangovan S, Fletcher SL, Subbiah V, Rampa S, Nalliah R, Lee MK, Allareddy V.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Sep;118(3):271-7. doi: 10.1016/j.oooo.2014.04.015. Epub 2014 May 14.

PMID:
24984810
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk